AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2015
Mar 3, 2015
29755_dirs_2015-03-03_381b7197-1ec1-4130-82d7-731d03875583.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2015-02-04
Reporting Person: GONZALEZ RICHARD A (Director, Chairman of the Board and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-04 | Common stock, $0.01 par value | G | 2400 | — | Disposed | 550756 | Direct |
| 2015-02-27 | Common stock, $0.01 par value | F | 43784 | $60.52 | Disposed | 506972 | Direct |
| 2015-02-28 | Common stock, $0.01 par value | F | 24825 | $60.50 | Disposed | 482147 | Direct |
Footnotes
F1: Reflects the transfer of 1,238 shares of AbbVie stock that was exempt from Section 16.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4